Targeted electrode-based modulation of neural circuits for depression

Journal of Clinical Investigation

Volumn 119, Issue 4, 2009, Pages 717-725

  Mayberg, Helen S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

BRAIN DEPTH STIMULATION; BRAIN DYSFUNCTION; DEPRESSION; DRUG EFFECT; DRUG TARGETING; ELECTRODE; GENETIC MODEL; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MOLECULAR MODEL; NEUROCHEMISTRY; NEUROIMAGING; NEUROMODULATION; NEUROSCIENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; BIOLOGICAL MODEL; BRAIN; ELECTROSTIMULATION THERAPY; METHODOLOGY; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY;

ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSION; ELECTRIC STIMULATION THERAPY; ELECTRODES; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, NEUROLOGICAL; NERVE NET; POSITRON-EMISSION TOMOGRAPHY;

EID: 65249086190     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38454     Document Type: Review

References (124)

1. McKenna, M.T., Michaud, C.M., Murray, C.J., and Marks, J.S. 2005. Assessing the burden of disease in the United States using disability-adjusted life years. Am. J. Prev. Med. 28:415-423.
2. Warden, D., Rush, A.J., Trivedi, M.H., Fava, M., and Wisniewski, S.R. 2007. The STAR*D Project results: a comprehensive review of findings. Curr. Psychiatry Rep. 9:449-459.
3. Holtzheimer, P.E., and Nemeroff, C.B. 2008. Novel targets for antidepressant therapies. Curr. Psychiatry Rep. 10:465-473.
4. Davidson, R.J., Pizzagalli, D., Nitschke, J.B., and Putnam, K. 2002. Depression: perspectives from affective neuroscience. Annu. Rev. Psychol. 53:545-574.
5. Phillips, M.L., Drevets, W.C., Rauch, S.L., and Lane, R. 2003. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biol. Psychiatry. 54:515-528.
6. Mayberg, H.S. 2003. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 65:193-207.
7. Fitzgerald, P.B., Laird, A.R., Maller, J., and Daskalakis, Z.J. 2008. A meta-analytic study of changes in brain activation in depression. Hum. Brain Mapp. 29:683-695.
8. Drevets, W.C., Price, J.L., and Furey, M.L. 2008. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 213:93-118.
9. Mayberg, H.S. 1997. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatry Clin. Neurosci. 9:471-481.
10. Mayberg, H.S., et al. 1999. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am. J. Psychiatry. 156:675-682.
11. Mayberg, H.S., et al. 2005. Deep brain stimulation for treatment-resistant depression. Neuron. 45:651-660.
12. Lozano, A.M., et al. 2008. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol. Psychiatry. 64:461-467.
13. Mayberg, H.S. 1994. Frontal lobe dysfunction in secondary depression. J. Neuropsychiatry Clin. Neurosci. 6:428-442.
14. McEwen, B.S., and Seeman, T. 1999. Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann. N. Y. Acad. Sci. 896:30-47.
15. Kendler, K.S., Thornton, L.M., and Gardner, C.O. 2001. Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. Am. J. Psychiatry. 158:582-586.
16. Caspi, A., et al. 2003. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 301:386-389.
17. Hasler, G., Drevets, W.C., Manji, H.K., and Charney, D.S. 2004. Discovering endophenotypes for major depression. Neuropsychopharmacology. 29:1765-1781.
18. Robinson, R.G., Kubos, K.L., Starr, L.B., Rao, K., and Price, T.R. 1984. Mood disorders in stroke patients. Importance of location of lesion. Brain. 107:81-93.
19. Koenigs, M., et al. 2008. Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J. Neurosci. 28:12341-12348.
20. Sheline, Y.I. 2003. Neuroimaging studies of mood disorder effects on the brain. Biol. Psychiatry. 54:338-352.
21. Drevets, W.C., et al. 1997. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:824-827.
22. Pizzagalli, D.A., et al. 2004. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol. Psychiatry. 9:325, 395-405.
23. Ongur, D., Drevets, W.C., and Price, J.L. 1998. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. U. S. A. 95:13290-13295.
24. Bowley, M.P., Drevets, W.C., Ongur, D., and Price, J.L. 2002. Low glial numbers in the amygdala in major depressive disorder. Biol. Psychiatry. 52:404-412.
25. Harrison, P.J. 2002. The neuropathology of primary mood disorder. Brain. 125:1428-1449.
26. Rajkowska, G., and Miguel-Hidalgo, J.J. 2007. Gliogenesis and glial pathology in depression. CNS Neurol. Disord. Drug Targets. 6:219-233.
27. McEwen, B.S., and Magarinos, A.M. 1997. Stress effects on morphology and function of the hippocampus. Ann. N. Y. Acad. Sci. 821:271-284.
28. Pezawas, L., et al. 2005. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8:828-834.
29. Radley, J.J., et al. 2008. Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex. J. Comp. Neurol. 507:1141-1150.
30. Banasr, M., and Duman, R.S. 2007. Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol. Disord. Drug Targets. 6:311-320.
31. Krishnan, V., and Nestler, E.J. 2008. The molecular neurobiology of depression. Nature. 455:894-902.
32. Airan, R.D., et al. 2007. High-speed imaging reveals neurophysiological links to behavior in an animal model of depression. Science. 317:819-823.
33. Diorio, D., Viau, V., and Meaney, M.J. 1993. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary- adrenal responses to stress. J. Neurosci. 13:3839-3847.
34. Barbas, H., Saha, S., Rempel-Clower, N., and Ghashghaei, T. 2003. Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neurosci. 4:25.
35. Baxter, L.R., Jr., et al. 1985. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch. Gen. Psychiatry. 42:441-447.
36. Drevets, W.C., et al. 1992. A functional anatomical study of unipolar depression. J. Neurosci. 12:3628-3641.
37. Wang, L., et al. 2008. Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. Psychiatry Res. 163:143-155.
38. Tremblay, L.K., et al. 2005. Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch. Gen. Psychiatry. 62:1228-1236.
39. Osuch, E.A., et al. 2000. Regional cerebral metabolism associated with anxiety symptoms in affective disorder patients. Biol. Psychiatry. 48:1020-1023.
40. Brody, A.L., et al. 2001. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol. Psychiatry. 50:171-178.
41. Dunn, R.T., et al. 2002. Principal components of the Beck Depression Inventory and regional cerebral metabolism in unipolar and bipolar depression. Biol. Psychiatry. 51:387-399.
42. Drevets, W.C., et al. 2002. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behav. 71:431-447.
43. Videbech, P., et al. 2002. The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta. Psychiatr. Scand. 106:35-44.
44. Hariri, A.R., et al. 2005. A susceptibility gene for affective disorders and the response of the human amygdala. Arch. Gen. Psychiatry. 62:146-152.
45. McEwen, B.S. 1998. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338:171-179.
46. DeRubeis, R.J., et al. 2005. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch. Gen. Psychiatry. 62:409-416.
47. Nemeroff, C.B., et al. 2003. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc. Natl. Acad. Sci. U. S. A. 100:14293-14296.
48. Rush, A.J., et al. 2006. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am. J. Psychiatry. 163:1905-1917.
49. Kellner, C.H., et al. 2006. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch. Gen. Psychiatry. 63:1337-1344.
50. Lam, R.W., Chan, P., Wilkins-Ho, M., and Yatham, L.N. 2008. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can. J. Psychiatry. 53:621-631.
51. Nierenberg, A.A., Alpert, J.E., Gardner-Schuster, E.E., Seay, S., and Mischoulon, D. 2008. Vagus nerve stimulation: 2-year outcomes for bipolar versus unipolar treatment-resistant depression. Biol. Psychiatry. 64:455-460.
52. Schlaepfer, T.E., et al. 2008. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 33:368-377.
53. Malone, D.A., Jr., et al. 2008. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol. Psychiatry. 65:267-275.
54. Jimenez, F., et al. 2005. A patient with a resistant major depression disorder treated with deep brain stimulation in the inferior thalamic peduncle. Neurosurgery. 57:585-593; discussion 585-593.
55. Friston, K., Phillips, J., Chawla, D., and Buchel, C. 1999. Revealing interactions among brain systems with nonlinear PCA. Hum. Brain Mapp. 8:92-97.
56. Horwitz, B. 2004. Relating fMRI and PET signals to neural activity by means of large-scale neural models. Neuroinformatics. 2:251-266.
57. Margulies, D.S., et al. 2007. Mapping the functional connectivity of anterior cingulate cortex. Neuroimage. 37:579-588.
58. Mayberg, H.S., et al. 1997. Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 8:1057-1061.
59. Pizzagalli, D., et al. 2001. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am. J. Psychiatry. 158:405-415.
60. Little, J.T., et al. 1996. Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacol. Bull. 32:629-635.
61. Siegle, G.J., Carter, C.S., and Thase, M.E. 2006. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am. J. Psychiatry. 163:735-738.
62. Kennedy, S.H., et al. 2007. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am. J. Psychiatry. 164:778-788.
63. Chen, C.H., et al. 2007. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol. Psychiatry. 62:407-414.
64. Wu, J., et al. 1999. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am. J. Psychiatry. 156:1149-1158.
65. Seminowicz, D.A., et al. 2004. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage. 22:409-418.
66. Dougherty, D.D., et al. 2003. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J. Neurosurg. 99:1010-1017.
67. Salvadore, G., et al. 2009. Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol. Psychiatry. 65:289-295.
68. Greicius, M.D., et al. 2007. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol. Psychiatry. 62:429-437.
69. Eichelbaum, M., Ingelman-Sundberg, M., and Evans, W.E. 2006. Pharmacogenomics and individualized drug therapy. Annu. Rev. Med. 57:119-137.
70. Mayberg, H.S., et al. 2000. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol. Psychiatry. 48:830-843.
71. Goldapple, K., et al. 2004. Modulation of corticallimbic pathways in major depression: treatmentspecific effects of cognitive behavior therapy. Arch. Gen. Psychiatry. 61:34-41.
72. Kennedy, S.H., et al. 2001. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am. J. Psychiatry. 158:899-905.
73. Nobler, M.S., et al. 2001. Decreased regional brain metabolism after ECT. Am. J. Psychiatry. 158:305-308.
74. Pardo, J.V., et al. 2008. Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism. Neuroimage. 42:879-889.
75. Sheline, Y.I., et al. 2001. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry. 50:651-658.
76. Fu, C.H., et al. 2004. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry. 61:877-889.
77. Anand, A., et al. 2005. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology. 30:1334-1344.
78. Luborzewski, A., et al. 2007. Metabolic alternations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar depression. J. Psychiatr. Res. 41:606-615.
79. Mayberg, H.S., et al. 2002. The functional neuroanatomy of the placebo effect. Am. J. Psychiatry. 159:728-737.
80. Freo, U., Ori, C., Dam, M., Merico, A., and Pizzolato, G. 2000. Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies. Brain Res. 854:35-41.
81. Frechilla, D., Otano, A., and Del Rio, J. 1998. Effect of chronic antidepressant treatment on transcription factor binding activity in rat hippocampus and frontal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry. 22:787-802.
82. Watkins, E., and Teasdale, J.D. 2004. Adaptive and maladaptive self-focus in depression. J. Affect. Disord. 82:1-8.
83. Rush, A.J., Kovacs, M., Beck, A.T., Weissenburger, J., and Hollon, S.D. 1981. Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms. J. Affect. Disord. 3:221-229.
84. Brody, A.L., et al. 2001. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch. Gen. Psychiatry. 58:631-640.
85. Martin, S.D., Martin, E., Rai, S.S., Richardson, M.A., and Royall, R. 2001. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch. Gen. Psychiatry. 58:641-648.
86. Talbot, P.S., and Cooper, S.J. 2006. Anterior cingulate and subgenual prefrontal blood flow changes following tryptophan depletion in healthy males. Neuropsychopharmacology. 31:1757-1767.
87. Zald, D.H., Mattson, D.L., and Pardo, J.V. 2002. Brain activity in ventromedial prefrontal cortex correlates with individual differences in negative affect. Proc. Natl. Acad. Sci. U. S. A. 99:2450-2454.
88. Ghashghaei, H.T., Hilgetag, C.C., and Barbas, H. 2007. Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdala. Neuroimage. 34:905-923.
89. Hsu, D.T., and Price, J.L. 2007. Midline and intralaminar thalamic connections with the orbital and medial prefrontal networks in macaque monkeys. J. Comp. Neurol. 504:89-111.
90. Freedman, L.J., Insel, T.R., and Smith, Y. 2000. Subcortical projections of area 25 (subgenual cortex) of the macaque monkey. J. Comp. Neurol. 421:172-188.
91. Vertes, R.P. 2004. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse. 51:32-58.
92. Haber, S.N., Kim, K.S., Mailly, P., and Calzavara, R. 2006. Reward-related cortical inputs define a large striatal region in primates that interface with associative cortical connections, providing a substrate for incentive-based learning. J. Neurosci. 26:8368-8376.
93. Ongur, D., and Price, J.L. 2000. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex. 10:206-219.
94. Petrides, M., and Pandya, D.N. 2007. Efferent association pathways from the rostral prefrontal cortex in the macaque monkey. J. Neurosci. 27:11573-11586.
95. Benabid, A.L. 2003. Deep brain stimulation for Parkinson's disease. Curr. Opin. Neurobiol. 13:696-706.
96. Johansen-Berg, H., et al. 2008. Anatomical connectivity of the subgenual cingulate region targeted with DBS for treatment-resistant depression. Cereb. Cortex. 18:1374-1383.
97. Gutman, D.A., Holtzheimer, P.E., Behrens, T.E., Johansen-Berg, H., and Mayberg, H.S. 2008. A tractography analysis of two deep brain stimulation white matter targets for depression. Biol. Psychiatry. 65:276-282.
98. Vogt, B.A., Nimchinsky, E.A., Vogt, L.J., and Hof, P.R. 1995. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J. Comp. Neurol. 359:490-506.
99. Craig, A.D. 2002. How do you feel? Interoception: the sense of the physiological condition of the body. Nat. Rev. Neurosci. 3:655-666.
100. Northoff, G., et al. 2006. Self-referential processing in our brain - a meta-analysis of imaging studies on the self. Neuroimage. 31:440-457.
101. Phan, K.L., Wager, T., Taylor, S.F., and Liberzon, I. 2002. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. Neuroimage. 16:331-348.
102. Harvey, P.O., et al. 2005. Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroimage. 26:860-869.
103. Etkin, A., Egner, T., Peraza, D.M., Kandel, E.R., and Hirsch, J. 2006. Resolving emotional conflict: a role for the rostral anterior cingulate cortex in modulating activity in the amygdala. Neuron. 51:871-882.
104. Fossati, P., et al. 2003. In search of the emotional self: an FMRI study using positive and negative emotional words. Am. J. Psychiatry. 160:1938-1945.
105. Yoshimura, S., et al. 2009. Self-referential processing of negative stimuli within the ventral anterior cingulate gyrus and right amygdala. Brain Cogn. 69:218-225.
106. Ochsner, K.N., et al. 2004. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage. 23:483-499.
107. Zink, C.F., Pagnoni, G., Martin, M.E., Dhamala, M., and Berns, G.S. 2003. Human striatal response to salient nonrewarding stimuli. J. Neurosci. 23:8092-8097.
108. Siegle, G.J., Steinhauer, S.R., Thase, M.E., Stenger, V.A., and Carter, C.S. 2002. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry. 51:693-707.
109. Koechlin, E., Ody, C., and Kouneiher, F. 2003. The architecture of cognitive control in the human prefrontal cortex. Science. 302:1181-1185.
110. Knutson, B., and Greer, S.M. 2008. Anticipatory affect: neural correlates and consequences for choice. Philos. Trans. R Soc. Lond. B Biol. Sci. 363:3771-3786.
111. Myers, K.M., and Davis, M. 2007. Mechanisms of fear extinction. Mol. Psychiatry. 12:120-150.
112. Santini, E., Quirk, G.J., and Porter, J.T. 2008. Fear conditioning and extinction differentially modify the intrinsic excitability of infralimbic neurons. J. Neurosci. 28:4028-4036.
113. Izhikevich, E.M., and Edelman, G.M. 2008. Largescale model of mammalian thalamocortical systems. Proc. Natl. Acad. Sci. U. S. A. 105:3593-3598.
114. Palomero-Gallagher, N., Vogt, B.A., Schleicher, A., Mayberg, H.S., and Zilles, K. 2008. Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum. Brain Mapp. Online publication ahead of print. doi:10.1002/hbm.20667.
115. Pape, H.C., Narayanan, R.T., Smid, J., Stork, O., and Seidenbecher, T. 2005. Theta activity in neurons and networks of the amygdala related to long-term fear memory. Hippocampus. 15:874-880.
116. Fried, I., et al. 1999. Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J. Neurosurg. 91:697-705.
117. McCracken, C.B., and Grace, A.A. 2007. Highfrequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. J. Neurosci. 27:12601-12610.
118. Belujon, P., and Grace, A.A. 2008. Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow. J. Neurosci. 28:9797-9805.
119. Zhang, F., Aravanis, A.M., Adamantidis, A., de Lecea, L., and Deisseroth, K. 2007. Circuit-breakers: optical technologies for probing neural signals and systems. Nat. Rev. Neurosci. 8:577-581.
120. Benabid, A.L., Pollak, P., Louveau, A., Henry, S., and de Rougemont, J. 1987. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl. Neurophysiol. 50:344-346.
121. DeLong, M.R., and Wichmann, T. 2007. Circuits and circuit disorders of the basal ganglia. Arch. Neurol. 64:20-24.
122. Li, S., Arbuthnott, G.W., Jutras, M.J., Goldberg, J.A., and Jaeger, D. 2007. Resonant antidromic cortical circuit activation as a consequence of highfrequency subthalamic deep-brain stimulation. J. Neurophysiol. 98:3525-3537.
123. Trost, M., et al. 2006. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage. 31:301-307.
124. Poston, K.L., and Eidelberg, D. 2008. Network biomarkers for the diagnosis and treatment of movement disorders. Neurobiol. Dis. Online publication ahead of print. doi:10.1016/j.nbd.2008.09.026.